These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2158079)

  • 1. Transcription of adenovirus and HeLa cell genes in the presence of drugs that inhibit topoisomerase I and II function.
    Schaak J; Schedl P; Shenk T
    Nucleic Acids Res; 1990 Mar; 18(6):1499-508. PubMed ID: 2158079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J; Schedl P; Shenk T
    J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of topoisomerases in replication, transcription, and packaging of the linear adenovirus genome.
    Wong ML; Hsu MT
    J Virol; 1990 Feb; 64(2):691-9. PubMed ID: 2153235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE; Rowe TC
    Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the DNA topoisomerase II inhibitor, VM26, on transcriptional initiation in vitro.
    Preston GM; White BA
    Life Sci; 1990; 46(18):1309-18. PubMed ID: 2161065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
    Matsuo K; Kohno K; Takano H; Sato S; Kiue A; Kuwano M
    Cancer Res; 1990 Sep; 50(18):5819-24. PubMed ID: 2168282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novobiocin inhibits RNA polymerase III transcription in vitro by a mechanism distinct from DNA topoisomerase II.
    Gottesfeld JM
    Nucleic Acids Res; 1986 Mar; 14(5):2075-88. PubMed ID: 3008085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide.
    Hwang JL; Shyy SH; Chen AY; Juan CC; Whang-Peng J
    Cancer Res; 1989 Feb; 49(4):958-62. PubMed ID: 2536295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of VM26, a specific inhibitor of type II DNA topoisomerase, on SV40 chromatin replication in vitro.
    Richter A; Strausfeld U
    Nucleic Acids Res; 1988 Nov; 16(21):10119-29. PubMed ID: 2848217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the DNA catenation activity of type II topoisomerase by VP16-213 and VM26.
    Minocha A; Long BH
    Biochem Biophys Res Commun; 1984 Jul; 122(1):165-70. PubMed ID: 6331440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of VM26 (teniposide), a specific inhibitor of type II DNA topoisomerase, on SV40 DNA replication in vivo.
    Richter A; Strausfeld U; Knippers R
    Nucleic Acids Res; 1987 Apr; 15(8):3455-68. PubMed ID: 3033604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons.
    Hsiang YH; Liu LF
    J Biol Chem; 1989 Jun; 264(17):9713-5. PubMed ID: 2542330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.
    Zhang H; Wang JC; Liu LF
    Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1060-4. PubMed ID: 2829214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of topoisomerase II does not inhibit transcription of RNA polymerase I and II genes.
    Dunaway M
    Mol Cell Biol; 1990 Jun; 10(6):2893-900. PubMed ID: 2160588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
    Bertrand R; Solary E; Jenkins J; Pommier Y
    Exp Cell Res; 1993 Aug; 207(2):388-97. PubMed ID: 7688316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the type I DNA topoisomerase gene in adenovirus-5 infected human cells.
    Romig H; Richter A
    Nucleic Acids Res; 1990 Feb; 18(4):801-8. PubMed ID: 2156232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral control regions activated by E1A and the cAMP response element bind to the same factor.
    Hardy S; Shenk T
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4171-5. PubMed ID: 2837758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of fostriecin, novobiocin, and camptothecin, inhibitors of DNA topoisomerases, on DNA replication and repair in human cells.
    Gedik CM; Collins AR
    Nucleic Acids Res; 1990 Feb; 18(4):1007-13. PubMed ID: 2156221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo localization of DNA topoisomerase II cleavage sites on Drosophila heat shock chromatin.
    Rowe TC; Wang JC; Liu LF
    Mol Cell Biol; 1986 Apr; 6(4):985-92. PubMed ID: 3023886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of topoisomerases I and II arrest DNA replication, but do not prevent nucleosome assembly in vivo.
    Annunziato AT
    J Cell Sci; 1989 Aug; 93 ( Pt 4)():593-603. PubMed ID: 2558122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.